Research Notes

Stay informed with the most recent market and company research insights.

A man sitting at a table with a glass of orange juice.

Research Notes

1H in-line; higher ASP; unusual kids/channel capacity

Cochlear
3:27pm
February 19, 2024
1H was pre-released, with >10% top and bottom line growth and strong OCF. Cochlear Implants (CI units +14%; sales +22% cc) and Services (+29% cc) drove the result, on strong global demand and solid uptake of the Nucleus 8 (N8) sound processor, while Acoustics was down (-9% cc) on lower overall demand. An “abnormal” ASP increase and “unusual” strength in children supported CI growth, most likely due to COVID catch-up surgeries and better audiology capacity. These likely one-offs, along with slowing CI growth, limited GPM expansion and ongoing elevated opex, portend modest near term operating leverage, in our view. We make no changes to FY24-26 estimates or A$290.45 price target. HOLD.

Investor Day

Macquarie Group
3:27pm
February 19, 2024
MQG’s 2024 investor day lowered outlook expectations for the year, mainly on reduced transaction activity in Macquarie Asset Management (MAM) and Macquarie Capital (MC). The investor day itself focused on MQG’s operations in Asia and Banking and Financial Services (BFS - our key points are below). Broadly we see both these areas as having good growth pathways going forward. We downgrade our MQG FY24F/FY25F EPS by ~-7%/-2% respectively on softer deal flow activity. Our target price is set at ~A$189 with our earnings changes offset by a valuation roll-forward. With upside to our valuation reduced, we move MQG to a HOLD call, with the stock trading at fair value, in our view (-21x FY24F EPS).

Defensive attributes and deeper value

New Hope Group
3:27pm
February 19, 2024
We update for 2Q production and trimmed NEWC price forecasts. We think dividend expectations should be moderated at the 1H Result March 19th. NHC’s defensive attributes – cash margins, balance sheet, steady dividends - appear to have supported a recent premium relative to more leveraged peers. Maintain Hold as NHC trades near to fair value. Our forecast 7-8% yield looks like sound compensation as investors await the next upswing.

Good times roll on, but valuation puts us on hold

Goodman Group
3:27pm
February 18, 2024
GMG continued its upgrade trend, with FY24 EPS growth guidance increasing from +9% to +11%, implying what appears to be a conservative sequential decline of 23% (hoh). The 1H24 result beat VA consensus EPS expectations by 13%, with the standout being the development division, supported by a larger proportion of developments being undertaken on balance sheet (higher margin). The business continues to benefit from the structural demand drivers of the digital economy, namely increased investment in technology and tenant’s need to maximise productivity. This has seen data centre projects rise to 37% of WIP. At $28.5/sh, the stock is trading c.1 standard deviation expensive and at a 12 month forward PER of 27x. For a business growing mid to high double digits, the stock isn’t cheap. Offsetting this is the quality: a portfolio of global assets spanning the most attractive subsectors of the real estate market and a management team capable of delivering EPS growth. Weighing this up, we see GMG as a great business and an essential part of any real estate allocation but too expensive to be a buyer at these prices, despite the earnings upside.

Still trending the right way

QBE Insurance Group
3:27pm
February 18, 2024
QBE’s FY23 NPAT (A$1.36bn) was -2% below consensus (A$1.383bn), with FY24 guidance also slightly softer than expected. While headline numbers were marginally weaker than hoped, fundamentally we saw this as a good FY23 result delivering a 16% ROE, and with a very strong balance sheet (PCA capital ratio of 1.82x versus 1.6x-1.8x target). In our view, the QBE investment thesis still remains very much intact, with the company on track to deliver ~25% EPS growth in FY24, whilst trading on a sub 10x PE multiple. This is too cheap in our view. We lower our QBE FY24F/FY25F EPS by ~-2%-3% on slightly softer GWP and margin assumptions. Our PT rises slightly to A$17.96 (previously A$17.56) with our earnings changes offset by a valuation roll-forward.

Painting a picture of growth

Cleanaway Waste Management
3:27pm
February 18, 2024
1H24 delivered the strong EBIT growth required to contribute to management incentive targets in FY26. However, there were headwinds to EPS and cashflow tracking at the same pace. Our target price lifts 14 cps to $2.54, from forecast upgrades (+4 cps) and valuation roll-forward (+10 cps). HOLD retained. At current prices we estimate a 12 month TSR of -3% and a five year IRR of c.7% pa.

A bit soft at the headline level

Insurance Australia Group
3:27pm
February 18, 2024
IAG’s 1H23 NPAT (A$407m) was down -13% on the pcp, and ~-7% below Visible Alpha consensus. While IAG’s headline result numbers were a bit softer than expected, full year guidance was re-affirmed, and IAG does enter 2H24 with its underlying insurance margin (UIM) seemingly already tracking around 15%. We downgrade IAG FY24F/FY25F EPS by -6%/-2% on slightly softer UIM forecasts and higher interest expense. Our PT is set at A$6.17 (previously A$6.32). We believe IAG is now generally tracking in the right direction operationally after a difficult few years, however, with <10% upside to our valuation we maintain our HOLD call.

When expectations are too high

Inghams
3:27pm
February 16, 2024
ING reported the strongest 1H result in its listed life. However, it was the materially softer than expected volume growth in Australia which disappointed following weakness in the ‘out of home’ channels. Management’s outlook commentary was vague as usual and slightly cautious. However, its commentary around the 1H/2H skew is unchanged. Our EBITDA forecasts are therefore unchanged while NPAT falls slightly due to higher tax. Given expectations were high leading into this result following strong share price performance in recent months, the stock was sold off given there was no beat and outlook commentary was mixed. However, we think the stock has been severely oversold. Trading on an FY25F PE of 11.1x and an attractive dividend yield of 6.1% fully franked, we maintain an Add rating.

Elevated costs impact the half

Aust Securities Exchange
3:27pm
February 16, 2024
Despite revenue growth of 2.4% on pcp to ~A$512m, ASX’s 1H24 result was a miss versus market consensus at NPAT (~A$231m, -8% on pcp and ~6% under consensus) on higher total costs than expected (~A$221m, +27% on pcp). We alter our FY24F-FY26F EPS by ~-2-+2% on higher operating expenses near term with an improved margin profile (cost rationalisation) medium-term. Our price target increases to A$62.70 (from A$60.20). Trading on ~26.5x MorgE FY24F PE, slightly above its 10-year average, we still see the elevated expense profile as weighing on the stock near-term. Hold maintained.

1H24: portfolio re-mixing

HomeCo Daily Needs REIT
3:27pm
February 16, 2024
Portfolio fundamentals remain solid and properties continue to re-weight towards higher growth Daily Needs assets vs Large Format Retail. One acquisition and four divestments to settle in 2H24. LFL income grew 4% which is in line with guidance and the active development pipeline remains on track to complete in 2H24 which will assist in valuation uplifts. Planning on new developments valued at +$530m is underway. NTA $1.44. FY24 guidance reaffirmed comprising FFO of 8.6c and DPS of 8.3c. We retain an Add rating with a price target of $1.37.

News & Insights

Michael Knox, Chief Economist, reveals how the OECD and RBA’s outdated assumptions about global trade fail to account for China’s Marxist-Leninist economic strategies.

This morning, I was asked to discuss Sarah Hunter’s presentation from yesterday. Sarah, the Assistant Governor and Chief Economist at the Reserve Bank of Australia (RBA), delivered a detailed and competent discussion on the conventional view of tariffs’ impact on the international economy. She highlighted that tariffs typically increase inflation and reduce economic output, a perspective echoed by the OECD in a similar presentation overnight. Sarah’s analysis focused on the potential shocks tariffs could cause, particularly their effects on GDP and inflation.

Drawing on my experience as an Australian trade commissioner and my work in Australian embassies, I found her presentation particularly interesting. My background allowed me to bring specialist knowledge to the conversation, which I believe gave me an edge. Notably, I observed that the RBA seems to lack analysts closely tracking individual policymakers in the Trump administration, such as Scott Bessent, whose views on tariffs and competition differ from the general assumptions. The conventional view assumes a world of perfectly competitive countries adhering to international trade rules and unlikely to engage in conflict—a scenario that doesn’t align with the current global trade environment, especially between China and the United States.

China, operating as a Marxist-Leninist economy, aims to dominate global markets by building monopolies in areas like rare earths, nickel, copper, and other base metals. It maintains a managed exchange rate, despite promises to the International Monetary Fund for a freely floating currency. If China allowed its currency, the RMB, to float, it would likely appreciate significantly, increasing imports and reducing its trade surplus. This would create a more balanced international trade environment, potentially reducing the need for other countries to impose tariffs. However, major institutions like the OECD and RBA seem to misjudge the nature of this trade shock, relying on outdated assumptions about global trade dynamics.

The international community also appears to overlook specific U.S. policy intentions, such as those articulated by figures like Peter Navarro and Scott Bessent. The U.S. aims to use tariffs selectively to bolster industries like pharmaceuticals, precision manufacturing, and motor vehicles. This misunderstanding leads public institutions to perceive unspecified risks, as reflected in Sarah’s otherwise able presentation. Because the RBA and similar institutions view the world as fraught with undefined risks, they are inclined to keep interest rates low, responding to perceived threats rather than an equilibrium model.

Interestingly, data from the U.S. economy contradicts the expected negative impacts of tariffs. The Chicago Fed National Activity Indicator, a reliable gauge of economic growth since the 2008 financial crisis, shows U.S. growth above the long-term trend for the first four months of this year. This suggests resilience despite tariff-related shocks. Ideally, growth will slow later this year, prompting the Federal Reserve to cut rates, facilitating a soft landing and a decline in the U.S. dollar to boost global commodity prices. However, this nuanced outlook wasn’t evident in yesterday’s presentation.

Moreover, the anticipated rise in U.S. inflation due to tariffs isn’t materialising. Scott Bessent recently noted that U.S. CPI inflation is lower than expected, with core inflation shown as the (16% trimmed mean) at 3% for the past two months . Core inflation  excluding  food and energy CPI  is only at 2.8%. This suggests that Chinese suppliers are absorbing tariff costs to maintain market share, rather than passing them on as higher prices. Recent Chinese data supports this, showing a slight decline in manufacturing confidence and coal consumption, indicating reduced factory output and electricity use. This points to a modest slowdown in China’s economy. So far the expected negative effects on U.S. prices and output are not occurring.

In summary, the fears expressed by institutions like the RBA and OECD about the Trump administration’s trade policies appear overstated. The U.S. economy is not experiencing the predicted declines in output or increases in inflation. While these effects may emerge later, the current data suggests that the risks are not as severe as anticipated, highlighting a disconnect between theoretical models and real-world outcomes.

Read more
Michael Knox outlines the economic outlook for growth and inflation in the U.S., the Euro area, China, India, and Australia, drawing data from the International Monetary Fund, the Congressional Budget Office, European sources, and his own analysis for Australia.

Today, I’m presenting the first page of my updated presentation, which focuses on GDP growth and inflation expectations for major economies. Before diving into that, I want to clarify a point about U.S. trade negotiations that has confused some media outlets.

In the previous Trump Administration ,there was single trade negotiator, Robert Lighthizer, held a cabinet position with the rank of Ambassador. This time, to expedite negotiations and give them more weight, Trump has appointed two additional cabinet-level officials to handle trade talks with different regions. For Asian economies, Scott Bessent and Ambassador Jamison Greer, who succeeded Lighthizer and previously served on the White House staff, are managing negotiations, including those with China. For Europe, Howard Lutnick, the Commerce Secretary, and Ambassador Greer are negotiating with the European Trade Representative. When the EU representative visits Washington, D.C., they meet with Lutnick and Greer, while Chinese or Japanese representatives engage with Bessent and Greer.

In my presentation today, I’m outlining the economic outlook for growth and inflation in the U.S., the Euro area, China, India, and Australia, drawing data from the International Monetary Fund, the Congressional Budget Office, European sources, and my own analysis for Australia.

For the U.S., the best-case scenario is a soft landing, with growth slowing but remaining positive at 1.3% this year and rising to 1.7% next year. This slowdown allows the Federal Reserve to continue cutting interest rates, leading to a decline in the U.S. dollar. This in turn ,triggers a recovery in commodity prices. These prices have stabilized and are now trending upward, with an expected acceleration as the dollar weakens.

U.S. headline inflation is projected to be just below 3% next year, with higher figures this year driven by tariff effects.



Global Economic Perspective

In the Euro area, growth is accelerating slightly, from just under 1% this year to 1.2% next year, with inflation expected to hit the 2% target this year and dip to 1.9% next year.

China’s GDP growth is forecast  at 4% for both this year and next, a step down from previous 5% rates, reflecting a significant slump in domestic demand and very low inflation  Chinese Inflation is only  :   0.2% last year, 0.4% this year, and 0.9% next year.  Despite a massive fiscal push, with a budget deficit around 8% of GDP, China’s debt-to-GDP ratio is rising faster than the U.S.. Yet this is  yielding more modest  domestic growth.

India, on the other hand, continues to outperform, with 6.5% GDP growth last year, 6.2% this year, and  6.3%  next year, surpassing earlier projections.

Read more
In our International Reporting Season Review, we provide an overview of the March 2025 quarterly results season for companies in the Americas, Europe and Asia.

Positive earnings surprise

In our International Reporting Season Review, we provide an overview of the March 2025 quarterly results season for companies in the Americas, Europe and Asia. For all the volatility in markets caused by US trade policy, the results were positive. For all the 187 high profile and blue-chip companies in our International Watchlist, the median EPS beat vs consensus was 3.2%, nearly twice that recorded in the December quarter (1.8%). 37% of companies exceeded consensus EPS expectations by more than 5% and only 9% missed by more than 5%. Communication Services was the most positive sector, led by Magnificent 7 companies Alphabet and Meta Platforms. The median EPS beat in that sector was 13%. Consumer Discretionary was the biggest disappointment (though only a mild one) with EPS falling 0.6% short of analyst estimates on a median basis.

Alphabet and Meta among the best performers

Across our Watchlist, some of the best performing stocks in terms of EPS beats were Alphabet, Boeing, Uniqlo-owner Fast Retailing, Meta Platforms, Newmont and The Walt Disney Company. Notable misses came from insurance broker Aon, BP, PepsiCo, Starbucks, Tesla and UnitedHealth. The latter saw by far the worst share price performance over reporting season, its earnings weakness compounded by the resignation of its CEO and the launch of a fraud investigation by the Department of Justice. British luxury fashion label Burberry had the best performing share price as it gains traction in its turnaround plan.

Tariffs were the main talking point (of course)

The timing of President Trump’s ‘Liberation Day’ on 2 April, just before the March quarter results started rolling in, guaranteed that US tariffs would be the main talking point throughout reporting season. Most companies took the line that higher tariffs presented a material risk to global growth and inflation. The rapidly shifting sands of US trade policy mean the impact of tariffs is highly uncertain. This didn’t stop many companies from trying to estimate the impact on their profits. This ranged from the very precise ($850m said RTX) to the extremely vague (‘a few hundred million dollars’ hazarded Abbott Laboratories). The rehabilitation of AI as a systemic driver of long-term value was a key theme of reporting season, with many companies reporting what Palantir Technologies described as an ‘unstoppable whirlwind of demand’ and others indicating an increase in planned AI investment. The deterioration in consumer confidence was another key talking point, though most companies could only express concern about a possible future softening in demand rather than any actual evidence of a hit to sales.

Our International Focus List continues to outperform

In this report, we also report on the performance of the Morgans International Focus List, which is now up 25.3% since inception last year, outperforming the benchmark S&P 500 by 20.4%.


Morgans clients receive exclusive insights such as access to our latest International Reporting Season article.

Contact us today to begin your journey with Morgans.

      
Contact us
      
      
Find an adviser
      
Read more